Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zagros Darou is a leading Iranian pharmaceutical manufacturer focused on the development and production of generic medicines. Founded in 2003, the company operates a large-scale manufacturing facility in Semnan, Iran, equipped for the production of various solid dosage forms. Their extensive product portfolio includes treatments for cardiovascular diseases, gastrointestinal disorders, and metabolic conditions. The company emphasizes compliance with international Good Manufacturing Practice (GMP) standards to maintain high quality across its production lines. In addition to prescription pharmaceuticals, Zagros Darou produces a range of dietary supplements and over-the-counter products. The firm plays a vital role in the Iranian healthcare system by providing affordable alternatives to essential medications. Zagros Darou continues to expand its reach through strategic distribution and a growing interest in international export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zagrous Darou Pharmaceutical.